← SynDRA
5-(4-Bromobenzyl)-1,3-thiazol-2-amine
SynDRA canonical compound SYN1428117 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | KCNMA1 |
|---|
| Mechanism of action | calcium-activated potassium channel activator |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- NS19504
- 5-[(4-bromophenyl)methyl]-1,3-thiazol-2-amine
- 5-(4-Bromobenzyl)thiazol-2-amine
- NS-19504
- MFCD01910159
- 2-Thiazolamine, 5-[(4-bromophenyl)methyl]-
- 5-[(4-bromophenyl)methyl]-1,3-thiazole-2-ylamine
- 3wk9
- Oprea1_137648
- orb1309322
- SCHEMBL14341905
- GTPL14024
- GLXC-03303
- CNA06246
- BDBM50002342
- EBC-06338
- SBB084108
- STL120345
- AKOS000122195
- SDCCGSBI-0660585.P001
- BS-13920
- 5-[(4-bromophenyl)methyl]thiazol-2-amine
- DS-016494
- HY-110153
- CS-0033014
- ST50077632
- EN300-02544
- E98711
- T12255
- F856876
- 5-[(4-Bromophenyl)Methyl]-1,3-Thiazole-2-Amine
- F2121-0157
- S0F
Look up 5-(4-Bromobenzyl)-1,3-thiazol-2-amine in the interactive SynDRA portal →